Market Access/ News/ News FDA rejects Adamis opioid overdose therapy Zimhi, hitting share price Phil Taylor Adamis, opioid addiction, opioid crisis, Zimhi 0 Comment Shares in Adamis Pharmaceuticals have been poleaxed by an FDA decision to reject Zimhi, intended as a treatment Share X FDA rejects Adamis opioid overdose therapy Zimhi, hitting share price https://pharmaphorum.com/news/fda-rejects-adamis-opioid-overdose-therapy-zimhi-hitting-share-price/
News/ US FDA approves Adamis’ cheaper rival to EpiPen Richard Staines Adamis, fda, generic, Mylan, pricing 0 Comment Symjepi also smaller and more convenient. Share X FDA approves Adamis’ cheaper rival to EpiPen https://pharmaphorum.com/news/adamis-mylan-epipen/
